Welcome to our dedicated page for RELIEF THERAPEUTICS HLDG news (Ticker: RLFTF), a resource for investors and traders seeking the latest updates and insights on RELIEF THERAPEUTICS HLDG stock.
RELIEF THERAPEUTICS Holding SA, traded as RLFTF, is a biopharmaceutical company dedicated to providing innovative treatment options for select specialty, unmet, and rare diseases. The company focuses on advancing treatment paradigms and delivering improvements in efficacy, safety, and convenience to benefit patients. Relief Therapeutics offers a diversified portfolio of marketed products, proprietary platform technologies, and a targeted clinical development pipeline. With a mission to provide therapeutic relief to those suffering from rare diseases, Relief Therapeutics is led by an experienced team of industry leaders. Headquartered in Geneva, the company is listed on the SIX Swiss Exchange and quoted on the OTCQB.
RELIEF THERAPEUTICS Holding SA conducted an Extraordinary General Meeting where shareholders approved various proposals by a significant majority. Key decisions included the election of new Board of Directors members, capital reduction, conditional share capital increase, compensation approval, discharge of the Board and Executive Committee, and amendments to Articles of Association. The meeting aimed at enhancing strategic direction and shareholder value, marking important transitions for the Company.
FAQ
What is the current stock price of RELIEF THERAPEUTICS HLDG (RLFTF)?
What is the market cap of RELIEF THERAPEUTICS HLDG (RLFTF)?
What does RELIEF THERAPEUTICS Holding SA do?
Where is RELIEF THERAPEUTICS Holding SA headquartered?
On which stock exchanges is RELIEF THERAPEUTICS Holding SA listed?
What is the mission of RELIEF THERAPEUTICS Holding SA?
Who leads RELIEF THERAPEUTICS Holding SA?
What are the core therapeutic areas of focus for RELIEF THERAPEUTICS Holding SA?
How can I learn more about RELIEF THERAPEUTICS Holding SA?
